Photo from wikipedia
Since the approval by the EMA of emicizumab for the care of severe haemophilia A without inhibitor, most of the patients of our haemophilia treatment centre started this new treatment.… Click to show full abstract
Since the approval by the EMA of emicizumab for the care of severe haemophilia A without inhibitor, most of the patients of our haemophilia treatment centre started this new treatment. Thanks to the setting of a therapeutic patient education program including three pharmaceutical consultations (PC), we could follow patients’ lifestyle evolution.
Keywords:
without inhibitor;
clinical perception;
haemophilia without;
emicizumab;
haemophilia;
assessment clinical
Journal Title: Haemophilia
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Haemophilia
Year Published: 2023
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!